Arlington, MA, United States of America

Lindong Weng

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: The General Hospital Corporation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lindong Weng. Retrieved from https://idiyas.com/inventor/lindong-weng-bpdwqmyj

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 4.2

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Lindong Weng: Innovator in Microfluidic Systems and Cryopreservation

Introduction

Lindong Weng is a notable inventor based in Arlington, MA, who has made significant contributions to the fields of microfluidics and cryopreservation. With a total of three patents to his name, Weng's work focuses on advancing methods that enhance biological sample processing and preservation.

Latest Patents

Weng's latest patents include innovative microfluidic systems designed to denude mammalian oocytes. These systems are configured to process liquid samples containing cumulus-oocyte complexes (COCs) in an automated and continuous manner. The technology aims to produce oocytes that are separate from surrounding cumulus cells. The systems feature a substrate and a channel with multiple sub-channels, each equipped with inlets, outlets, and stages arranged in series. Notably, some stages include constriction units with jagged internal surfaces that facilitate the removal of cumulus cells from COCs.

Another significant patent involves high subzero cryopreservation methods. This innovation is based on the discovery that endothelial cells exhibit improved attachment and viability after preservation when exposed to heterogeneous extracellular ice. By uniformly nucleating ice across the microvasculature using ice nucleating agents, the risk of intracellular ice formation is significantly reduced, enhancing the preservation of biological samples, organs, and organisms.

Career Highlights

Lindong Weng is currently associated with The General Hospital Corporation, where he continues to develop and refine his innovative technologies. His work has garnered attention for its potential applications in medical and biological research.

Collaborations

Weng collaborates with esteemed colleagues, including Mehmet Toner and Shannon Tessier, who contribute to the advancement of his research and innovations.

Conclusion

Lindong Weng's contributions to microfluidic systems and cryopreservation represent significant advancements in the field of biological research. His innovative patents are paving the way for improved methods in processing and preserving biological samples.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…